The U.S. Food and Drug Administration (FDA) approved NEXIUM® delayed release capsules in children ages 12 to 17 for the short-term treatment of gastroesophageal reflux disease (GERD). NEXIUM was tested in adolescents ages 12 to 17 in a randomized, double-blind parallel group study in which a total of 149 patients, ages 12 to 17, with clinically diagnosed GERD were treated with either NEXIUM 20mg or NEXIUM 40 mg once a day for up to eight weeks. Reported side effects included headache,...
Read moreMy 9 year-old has been diagnosed with GERD. Is it safe for him to be on Nexium? Yes. Earlier this year, the FDA approved Nexium for... Read more »
Pregnancy Tracker: 21 weeks, 3 days Size of the Baby: 10.5 ounces Biggest Obstacle: I'm tired because we're moving this weekend! ... Read more »
Last week Zogenix, Inc., a pharmaceutical company that develops products for treating central nervous system disorders and pain, announced... Read more »
In April, I reported on a new Migraine abortive medication, Trexima. Trexima combines sumatriptan (Imitrex) and naproxen sodium. Two... Read more »
The FDA has delayed approval for Actemra pending submission of extra product manufacturing and product label... Read more »
The U.S. Food and Drug Administration has approved the acid reflux drug Nexium for short-term use in children ages 1 to 11. The agency approved... Read more »
Source: First DataBank
Generic Name: ESOMEPRAZOLE DELAYED-RELEASE CAPSULE - ORAL Pronounced: (ES-oh-MEP-ra-zole) Uses Esomeprazole works by blocking acid production in... Read more »
A new formula of Nexium is now available in India for people with peptic ulcers and gastroesophageal reflux disorder. Torrent Pharmaceuticals has... Read more »
A small study has found that 61 percent of acid-reflux sufferers experience nocturnal acid breakthrough when taking Zegerid, compared with 92 percent... Read more »
The U.S. Food and Drug Administration (FDA) has delayed release of the extended-release ADHD medication Intuniv. According to drugmaker Shire,... Read more »